Methods for the isolation and analysis of Aβ from postmortem brain.

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Alzheimer's disease (AD) pathogenesis is linked to amyloid beta-protein (Aβ).
• Prior research predominantly used synthetic Aβ, limiting in vivo relevance.
• Studying endogenous Aβ from human brain tissue is crucial but challenging.

Purpose of the Study:

• To establish novel methods for analyzing distinct amyloid beta-protein (Aβ) species directly from human cortical tissue.
• To develop a bioassay for assessing the neurotoxic impact of Aβ on human neurons.
• To create a comprehensive platform for investigating Aβ activity and identifying neuroprotective strategies.

Main Methods:

• Developed three distinct protocols to isolate and study different Aβ fractions: diffusible, solubilized, and true dimers.
• Utilized induced pluripotent stem cell (iPSC)-derived human neurons for a neuritic integrity bioassay.
• Combined extraction methods with the bioassay to analyze Aβ species and their effects.

Main Results:

• Successfully isolated and characterized distinct Aβ species from human brain tissue.
• Identified disease-related activity specifically in isolated Aβ dimers.
• Demonstrated the neurotoxic effects of certain Aβ species on human neurons via the bioassay.

Conclusions:

• The developed methods provide a robust platform for studying endogenous amyloid beta-protein (Aβ) in Alzheimer's disease (AD) research.
• This approach allows for the investigation of specific Aβ species, particularly disease-relevant dimers.
• The findings facilitate the identification of therapeutic targets and strategies to counteract Aβ-mediated neurotoxicity.